(Total Views: 486)
Posted On: 06/22/2025 8:34:41 PM
Post# of 154592
He mentions the potential for "yearly PrEP" on the horizon...
Wow! What are the chances that the NIH project with End Date 6/30/25 entitled
A Solid-Phase, Long-Acting CCR5 Monoclonal Antibody for HIV Transmission
actually results out a time duration of action in excess of 1 year?
Or whether the half life exceeded 1 year?
Wow! What are the chances that the NIH project with End Date 6/30/25 entitled
A Solid-Phase, Long-Acting CCR5 Monoclonal Antibody for HIV Transmission
actually results out a time duration of action in excess of 1 year?
Or whether the half life exceeded 1 year?
Quote:
In specific aim 2, we will determine the length of time a single injection at the clinical dose can protect both male and female macaques against rectal transmission . In specific aim 3, we will determine the length of time a single injection of the clinical dose can protect against vaginal transmission in cycling female macaques .
(3)
(0)
